文献

J-GLOBAL ID：202102214732590179   整理番号：21A0188173

日本における化学療法誘発性悪心および嘔吐に対する制吐療法の最適化:2015年版の日本癌治療学会制吐薬適正使用ガイドライン更新概要

Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis

著者 (36件)： Aogi Kenjiro (Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan) ,  Takeuchi Hideki (Department of Breast Oncology, Saitama Medical University, Saitama, Japan) ,  Takeuchi Hideki (Department of Breast Surgical Oncology, Japan Organization of Occupational Health and Safety Yokohama Rosai Hospital, Yokohama, Japan) ,  Takeuchi Hideki (Department of Breast Oncology, Saitama Medical University International Medical Center, Saitama, Japan) ,  Saeki Toshiaki (Department of Breast Oncology, Saitama Medical University International Medical Center, Saitama, Japan) ,  Aiba Keisuke (Division of Clinical Oncology/Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan) ,  Aiba Keisuke (Todachuo General Hospital, Saitama, Japan) ,  Tamura Kazuo (General Medical Research Center, Fukuoka University Hospital, Fukuoka, Japan) ,  Iino Keiko (Department of Adult Nursing, National College of Nursing, Tokyo, Japan) ,  Imamura Chiyo K. (Department of Clinical Pharmacokinetics and Pharmacodynamics, Keio University, Tokyo, Japan) ,  Imamura Chiyo K. (Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan) ,  Okita Kenji (Department of Surgery, Surgical Oncology and Science, Sapporo Medical University Postgraduate School of Medicine, Sapporo, Hokkaido, Japan) ,  Okita Kenji (JR Sapporo Hospital, Sapporo, Hokkaido, Japan) ,  Kagami Yoshikazu (Division of Radiation Oncology, Department of Radiology, Showa University School of Medicine, Tokyo, Japan) ,  Tanaka Ryuhei (Department of Pediatric Hematology and Oncology, Saitama Medical University International Medical Center, Saitama, Japan) ,  Nakagawa Kazuhiko (Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan) ,  Fujii Hirofumi (Department of Clinical Oncology, Jichi Medical University, Tochigi, Japan) ,  Boku Narikazu (Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan) ,  Wada Makoto (Department of Psycho-Oncology and Palliative Medicine, Osaka International Cancer Institute, Osaka, Japan) ,  Akechi Tatsuo (Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan) ,  Iihara Hirotoshi (Department of Pharmacy, Gifu University Hospital, Gifu, Japan) ,  Ohtani Shoichiro (Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan) ,  Okuyama Ayako (Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan) ,  Ozawa Keiko (Department of Nursing, NTT Medical Center Tokyo, Tokyo, Japan) ,  Kim Yong-Il (Department of Medical Oncology, Seirei Hamamatsu General Hospital, Sizuoka, Japan) ,  Kim Yong-Il (Department of Medical Oncology, Yodogawa Christian Hospital, Osaka, Japan) ,  Sasaki Hidenori (Division of Medical Oncology, Hematology and Infectious Disease, Department of Medicine, Fukuoka University Hospital, Fukuoka, Japan) ,  Shima Yasuo (Department of Palliative Medicine, Tsukuba Medical Center Hospital, Ibaraki, Japan) ,  Takeda Masayuki (Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan) ,  Nagasaki Eijiro (Division of Clinical Oncology/Hematology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan) ,  Nagasaki Eijiro (Todachuo General Hospital, Saitama, Japan) ,  Nishidate Toshihiko (Department of Surgery, Surgical Oncology and Science, Sapporo Medical University Postgraduate School of Medicine, Sapporo, Hokkaido, Japan) ,  Nishidate Toshihiko (JR Sapporo Hospital, Sapporo, Hokkaido, Japan) ,  Higashi Takahiro (Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan) ,  Hirata Kouichi (Department of Surgery, Surgical Oncology and Science, Sapporo Medical University Postgraduate School of Medicine, Sapporo, Hokkaido, Japan) ,  Hirata Kouichi (JR Sapporo Hospital, Sapporo, Hokkaido, Japan)
資料名： International Journal of Clinical Oncology (Web)  (International Journal of Clinical Oncology (Web))
巻： 26  号： 1  ページ： 1-17  発行年： 2021年 
JST資料番号： U1599A  ISSN： 1341-9625  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 要約:癌患者は,化学療法誘発性悪心および嘔吐(CINV)に対...

シソーラス用語： ヒト ,...
準シソーラス用語： クリニカルクエスチョン ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0188173&from=J-GLOBAL&jstjournalNo=U1599A") }}

著者キーワード (3件)： 制吐 ,  化学療法による悪心と嘔吐 ,  臨床診療ガイドライン

分類 (3件)： 腫ようの薬物療法  (GE03032C) ,  消化器疾患の薬物療法  (GH05020G) ,  抗腫よう薬の臨床への応用  (GW16020L)

物質索引 (1件)： オランザピン

タイトルに関連する用語 (11件)： 日本 ,  化学療法 ,  悪心 ,  嘔吐 ,  制吐療法 ,  最適化 ,  制吐薬 ,  適正使用 ,  ガイドライン ,  更新 ,  概要